Dual Effect of Ziconotide in Primary Erythromelalgia.
| Autor: | Russo R; Pain Therapy Unit, Department of Hematology and Oncology, Pugliese-Ciaccio Hospital, Catanzaro, Italy., Caroleo MC; Department of Pharmacy and Health and Nutritional Sciences, University of Calabria, Italy., Cione E; Department of Pharmacy and Health and Nutritional Sciences, University of Calabria, Italy., Perri M; Department of Pharmacy and Health and Nutritional Sciences, University of Calabria, Italy., Paparo MT; Molecular Biology Unit, Department of Hematology and Oncology, Pugliese-Ciaccio Hospital, Catanzaro, Italy., Russo A; Molecular Biology Unit, Department of Hematology and Oncology, Pugliese-Ciaccio Hospital, Catanzaro, Italy. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Case reports in medicine [Case Rep Med] 2015; Vol. 2015, pp. 592170. Date of Electronic Publication: 2015 Nov 02. |
| DOI: | 10.1155/2015/592170 |
| Abstrakt: | Erythromelalgia (EM) is a rare disabling clinical syndrome more commonly known to affect the lower extremities. There is no single effective treatment for this disease that often requires a multidisciplinary approach. Herein, we report the case of a 31-year-old woman affected by primary erythromelalgia who was successfully treated with intrathecal Ziconotide. We also observed an unexpected result following therapy with Ziconotide. The legs and feet of the patient that at the time of admission were swollen and tumefied dramatically improved after one week of the drug administration. |
| Databáze: | MEDLINE |
| Externí odkaz: |
|